002044 美年健康
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)-2.2683.5563.6166.711-7.257
总资产报酬率 ROA (%)-0.9391.4181.4262.673-2.997
投入资产回报率 ROIC (%)-1.1521.7711.7833.339-3.674

边际利润分析
销售毛利率 (%)33.89541.35942.78342.78934.436
营业利润率 (%)-4.9555.7715.7248.112-4.732
息税前利润/营业总收入 (%)-1.4048.2978.47810.530-1.881
净利润/营业总收入 (%)-4.9863.5773.8226.140-5.822

收益指标分析
经营活动净收益/利润总额(%)91.636129.234130.093105.90854.528
价值变动净收益/利润总额(%)7.68710.8642.8455.835-3.422
营业外收支净额/利润总额(%)-0.525-7.242-3.388-4.2049.554

偿债能力分析
流动比率 (X)0.7860.8380.7820.7900.708
速动比率 (X)0.7660.8170.7580.7620.679
资产负债率 (%)53.35055.61156.75956.77655.917
带息债务/全部投入资本 (%)35.09635.79234.39533.09033.033
股东权益/带息债务 (%)145.841140.818143.015149.301151.767
股东权益/负债合计 (%)79.67272.69469.25969.68471.715
利息保障倍数 (X)-0.3982.8452.8823.836-0.561

营运能力分析
应收账款周转天数 (天)139.482100.55395.02088.553107.268
存货周转天数 (天)12.29311.92712.88613.04111.946